Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kauai: KPI-121 0.25% for Dry Eye Disease
NCT02188160Phase 2Completed
- Sponsor
- KALA BIO
- Start
- Jun 2014
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lifitegrast in dry eye disease (DED), sponsored by KALA BIO. Started Jun 2014; status: completed.
02
Drugs
lifitegrast
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT02188160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02188160.